The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2020

Filed:

Mar. 09, 2017
Applicant:

Hisamitsu Pharmaceutical Co., Inc., Tosu-shi, JP;

Inventors:

Masayuki Suzuki, Tsukuba, JP;

Hiroaki Okutsu, Tsukuba, JP;

Takashi Yasukochi, Tsukuba, JP;

Yasunori Takada, Tsukuba, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/407 (2006.01); A61K 47/10 (2017.01); A61K 47/06 (2006.01); A61K 9/70 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61M 37/00 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/407 (2013.01); A61K 9/7038 (2013.01); A61K 9/7046 (2013.01); A61K 9/7053 (2013.01); A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61K 31/55 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61M 37/00 (2013.01);
Abstract

A patch for administering asenapine includes a support layer, and an adhesive agent layer formed on the support layer and including an adhesive base agent and asenapine and/or a pharmaceutically acceptable salt thereof. The adhesive base agent has a content in a range of 10 to 90% by mass in the adhesive agent layer and includes a natural rubber, polyisobutylene, an alkyl vinyl ether(co)polymer, polyisoprene, polybutadiene, a styrene-butadiene copolymer, a styrene-isoprene copolymer, a styrene-isoprene-styrene block copolymer, or a combination thereof. When a content of the asenapine and/or pharmaceutically acceptable salt thereof in terms of free asenapine in the adhesive agent layer is 3.4 mg, an AUCfor a period starting from the time when the patch is brought into contact with a skin for 24 hours is 27,000 pg·hr/mL or more, and an AUCof an asenapine metabolite is 20% or less of the AUCof the free asenapine.


Find Patent Forward Citations

Loading…